Dantrolene requires Mg 2+ to arrest malignant hyperthermia
Rocky H. Choi, Xaver Koenig, Bradley S. Launikonis
Abstract
Rocky H. Choi, Xaver Koenig, Bradley S. Launikonis
Abstract
Significance The nature of overactive Ca 2+ release in malignant hyperthermia (MH) and the mechanism of action of the drug dantrolene that arrests MH events are poorly understood. Here, we show that dantrolene stops overactive Ca 2+ release by increasing the affinity of the ryanodine receptor (RyR) to Mg 2+ . In particular, Ca 2+ waves induced by MH triggers in human muscle are not affected by dantrolene unless Mg 2+ increases above resting levels, a condition met by the increase in MgATP hydrolysis during an MH episode. We suggest that only the combination of dantrolene and increased Mg 2+ can depress overactive Ca 2+ release and the resulting excessive heat production to arrest MH.
OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Significance The nature of overactive Ca 2+ release in malignant hyperthermia (MH) and the mechanism of action of the drug dantrolene that arrests MH events are poorly understood. Here, we show that dantrolene stops overactive Ca 2+ release by increasing the affinity of the ryanodine receptor (RyR) to Mg 2+ . In particular, Ca 2+ waves induced by MH triggers in human muscle are not affected by dantrolene unless Mg 2+ increases above resting levels, a condition met by the increase in MgATP hydrolysis during an MH episode. We suggest that only the combination of dantrolene and increased Mg 2+ can depress overactive Ca 2+ release and the resulting excessive heat production to arrest MH.
Key concepts: Dantrolene, Malignant hyperthermia, Ryanodine receptor, RYR1, Skeletal muscle, Chemistry, Muscle relaxant, Metabolite